← Back to Patent Explorer
US3048522A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for separating endocellular components and a composition produced thereby

Assignee: LABORATOIRES MILLOT
•
Filing: 1959-08-04
•
Granted: 1962-08-07
•
Expires: 1979-08-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Georges C Velley

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 22:54
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/37; A61K35/407

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 121 words
PROCESS FOR SEGREGATING ENDOCELLULAR COMPONENTS OF BIOLOGICAL CELLS, SAID CELLS BEING DERIVED FROM ANIMAL FETUS LIVER, WHICH COMPRISES CONFINING THE CELLS BETWEEN FINE MESH SCREENS, AXIALLY REVOLVING SAID SCREENS AT HIGH SPEED IN OPPOSED DIRECTIONS, WHILE URGING SUCH SCREENS TOWARD EACH OTHER, WITH RESULTANT MILD DISINTEGRATION OF THE CELLS FRICTIONALLY, INTO SUBSTANTIALLY THEIR WHOLE COMPONENTS FILTERING THE DISINTEGRATED CELLS TO TRANSMIT THE WHOLE ENDOCELLULAR COMPONENTS AND TO INTERCEPT THE CYTOPLASMIC RESIDUE OF THE CELLS AND COLLECTING THE ENDOCELLULAR COMPONENTS THUS PASSED, SAID ENDOCELLULAR COMPONENTS BEING DISPERSED AS THEY ARE COLLECTED, IN PHARMACOLOGICALLY ACCEPTABLE LIQUID, AND SAID LIQUID BEING SELECTED FROM THE GROUP CONSISTING OF PARENTERALLY INJECTABLE AQUEOUS LIQUIDS AND GASTROINTESTINALLY ABSORBABLE AQUEOUS LIQUIDS,AND SAID LIQUID INCLUDING 5% BY WEIGHT OF SACCHAROSE.
Claim 2
Dependent Claim 121 words
PROCESS FOR SEGREGATING ENDOCELLULAR COMPONENTS OF BIOLOGICAL CELLS, SAID CELLS BEING DERIVED FROM ANIMAL FETUS LIVER, WHICH COMPRISES CONFINING THE CELLS BETWEEN FINE MESH SCREENS, AXIALLY REVOLVING SAID SCREENS AT HIGH SPEED IN OPPOSED DIRECTIONS, WHILE URGING SUCH SCREENS TOWARD EACH OTHER, WITH RESULTANT MILD DISINTEGRATION OF THE CELLS FRICTIONALLY, INTO SUBSTANTIALLY THEIR WHOLE COMPONENTS FILTERING THE DISINTEGRATED CELLS TO TRANSMIT THE WHOLE ENDOCELLULAR COMPONENTS AND TO INTERCEPT THE CYTOPLASMIC RESIDUE OF THE CELLS AND COLLECTING THE ENDOCELLULAR COMPONENTS THUS PASSED, SAID ENDOCELLULAR COMPONENTS BEING DISPERSED AS THEY ARE COLLECTED, IN PHARMACOLOGICALLY ACCEPTABLE LIQUID, AND SAID LIQUID BEING SELECTED FROM THE GROUP CONSISTING OF PARENTERALLY INJECTABLE AQUEOUS LIQUIDS AND GASTROINTESTINALLY ABSORBABLE AQUEOUS LIQUIDS,AND SAID LIQUID INCLUDING 5% BY WEIGHT OF SACCHAROSE.

References Cited (Backward Citations)

GB207573A Cited
US1771526A Cited
US1999241A Cited
US2162863A Cited
US2154649A Cited
US2239345A Cited
US2910406A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1965-08-06 1966-02-05 1966-08-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1969-08-06 1970-02-05 1970-08-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1973-08-06 1974-02-05 1974-08-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag